Literature DB >> 21925915

The association between leptin and insulin levels in adults with cystic fibrosis.

S Ziai1, L Belson, A Malet, A Tardif, Y Berthiaume, L Coderre, R Rabasa-Lhoret.   

Abstract

UNLABELLED: Cystic fibrosis (CF)-related diabetes is an important complication of CF caused by a decrease in insulin secretion that is associated with weight loss, poor nutritional status and increased mortality. Leptin, a hormone secreted from white adipose tissue, has an important role in energy homoeostasis by inhibiting food intake and increasing energy expenditure. Leptin secretion can be increased by nutrient signals such as insulin. AIMS: Considering that leptin plays a role in energy homoeostasis and that CF is associated to poor weight gain and decreased insulin secretion, leptin levels in CF patients with different glucose tolerances were investigated and compared with those of healthy control subjects.
METHODS: Two-hour oral glucose tolerance tests (OGTT) were performed in 82 patients with CF and various glucose tolerances as well as in 17 healthy control subjects during which blood was withdrawn every 30 min to measure glucose and insulin. Fasting leptin, fibrinogen and fat mass were also measured, and body mass index (kg/m(2)) calculated for all participants. Early and late insulin secretion was separated by calculating the area under the curve from time 0 to 30 min and 30 to 120 min of the OGTT (AUC(0-30) and AUC(30-120)).
RESULTS: Leptin levels were comparable between CF patients and healthy control subjects. Interestingly, correlations were observed between leptin levels and insulin (AUC(0-120) and AUC(30-120)) after adjusting for gender and fat mass (P<0.05).
CONCLUSION: This study suggests a potential role of insulin in regulating leptin levels in adults with stable CF.
Copyright © 2011 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21925915     DOI: 10.1016/j.diabet.2011.07.003

Source DB:  PubMed          Journal:  Diabetes Metab        ISSN: 1262-3636            Impact factor:   6.041


  4 in total

1.  Circulating brain-derived neurotrophic factor, leptin, neuropeptide Y, and their clinical correlates in cystic fibrosis: a cross-sectional study.

Authors:  Jan K Nowak; Mariusz Szczepanik; Magdalena Trypuć; Andrzej Pogorzelski; Waldemar Bobkowski; Marcin Grytczuk; Alina Minarowska; Rafał Wójciak; Jaroslaw Walkowiak
Journal:  Arch Med Sci       Date:  2018-04-23       Impact factor: 3.318

2.  Plasma Leptin Is Elevated in Acute Exacerbation of Idiopathic Pulmonary Fibrosis.

Authors:  Mengshu Cao; Jeffery J Swigris; Xin Wang; Min Cao; Yuying Qiu; Mei Huang; Yonglong Xiao; Hourong Cai
Journal:  Mediators Inflamm       Date:  2016-08-25       Impact factor: 4.711

3.  The association between body composition, leptin levels and glucose dysregulation in youth with cystic fibrosis.

Authors:  Andrea Granados; Elizabeth A Beach; Andrew J Christiansen; Bruce W Patterson; Michael Wallendorf; Ana María Arbeláez
Journal:  J Cyst Fibros       Date:  2021-06-26       Impact factor: 5.527

4.  Adiponectin Expression Is Modulated by Long-Term Physical Activity in Adult Patients Affected by Cystic Fibrosis.

Authors:  Rita Polito; Ersilia Nigro; Ausilia Elce; Maria Ludovica Monaco; Paola Iacotucci; Vincenzo Carnovale; Marika Comegna; Monica Gelzo; Federica Zarrilli; Gaetano Corso; Giuseppe Castaldo; Aurora Daniele
Journal:  Mediators Inflamm       Date:  2019-09-09       Impact factor: 4.711

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.